Bryllan is a US-based CDMO specializing in the production and filling of potent and cytotoxic compounds, with a focus on aseptic powder and liquid filling for complex drug and device combination products. The company operates a high-containment, state-of-the-art facility in Brighton, Michigan, supporting both clinical and commercial supply of ADCs and other cytotoxic products.
Potent and cytotoxic compound filling, aseptic processing, ADC handling, drug-device combination products, high containment manufacturing
1 site worldwide
No reviews available yet.
No documents available.